(Q61833759)
Statements
Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma (English)
Youn H Kim
Madeleine Duvic
Erik Obitz
Anders Osterborg
Sean Whittaker
Thomas Schwarz
Roland Kaufmann
Kevin Cooper
Kim M Knudsen
Steen Lisby
Ole Baadsgaard
Susan J Knox
20 February 2007